Skip to main content

Joyce Meghan V.'s Form 4 filing

Guardant Health, Inc. (GH) · filed Jun 16, 2023

Accession no.
0001576280-23-000095
Filed
Jun 16, 2023
Trade date
Jun 14-15, 2023
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 2 non-derivative transactions and 3 derivative transactions. Open-market sales total $103.9K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Joyce Meghan V.CIK 0001770749Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 14, 2023COMMON STOCKMOption exerciseAcquired+5,531$0.00$06,990Direct
Jun 15, 2023COMMON STOCKSSaleDisposed−2,766$37.55−$103,863.34,224Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 14, 2023COMMON STOCKMOption exerciseDisposed−5,531$0.00$00Direct
Jun 14, 2023COMMON STOCKAGrant or awardAcquired+8,803$0.00$08,803Direct
Jun 14, 2023COMMON STOCKAGrant or awardAcquired+5,592$0.00$05,592Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)